Skip to main content

Table 1 Baseline characteristics of TB patients treated at DRH from January 2006 – December 2010

From: Mortality among tuberculosis patients under DOTS programme: a historical cohort study

Variables

HIV status

Total

Positive (n = 629)

Negative (n = 631)

Gender

 Male

341 (54.2)

440 (69.7)

781 (62.0)

 Female

288 (45.8)

191 (30.7)

479 (38.0)

Age group

  < 20

83 (13.2)

80 (12.7)

163 (12.9)

 20–29

110 (17.5)

288 (45.6)

398 (31.6)

 30–39

274 (43.6)

148 (23.5)

422 (33.5)

 40–49

101 (16.1)

36 (5.7)

137 (10.9)

  > 49

61 (9.7)

79 (12.5)

140 (11.1)

Residence

 Urban

600 (95.4)

606 (96.0)

1206 (95.7)

 Rural

29 (4.6)

25 (4.0)

54 (4.3)

Baseline weight

  < 20

43 (6.8)

31 (4.9)

74 (5.9)

 20–29

16 (2.5)

3 (0.5)

19 (1.5)

 30–39

45 (7.2)

63 (10.0)

108 (8.6)

 40–49

195 (31.0)

136 (21.6)

331 (26.3)

  > 49

330 (52.5)

398 (63.1)

728 (57.8)

CPT initiated

 No

186 (29.6)

581 (92.1)

767 (60.9)

 Yes

443 (70.4)

50 (7.9)

493 (39.1)

ART initiated

 No

348 (55.3)

631 (100)

979 (77.7)

 Yes

281 (44.7)

0 (0.0)

281 (22.3)

Type of TB

 Smear positive

67 (10.7)

140 (22.2)

207 (16.4)

 Smear negative

291 (46.3)

211 (33.4)

502 (39.8)

 EPTB

271 (43.1)

280 (44.4)

551 (43.7)

Treatment category

 New

539 (85.7)

514 (81.5)

1053 (83.6)

 Retreatment

90 (14.3)

117 (18.5)

207 (16.4)

Patient status

 Censored

516 (82.0)

627 (99.4)

1143 (90.7)

 Died

113 (18.0)

4 (0.6)

117 (9.3)

  1. CPT Cotrimoxazole preventive therapy, ART Antiretroviral therapy, TB Tuberculosis, EPTB-Extrapulmonary TB